http://www.023jfw.com/3t5befbk.html
Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial ...
WebApr 5, 2024 · Methods and Results The ChiOTEAF (Optimal Thromboprophylaxis in Elderly Chinese Patients With Atrial Fibrillation) registry is a prospective, multicenter, nationwide study conducted from October 2014 to December 2024. The primary outcomes of interest were the composite end point of all-cause death and thromboembolic events, as well as ... WebThe ChiOTEAF registry is designed to have aligned definitions of clinical features and comorbidities with a common case report form (CRF) and protocol with the EORP-AF registry, which makes the two registries comparable. EORP-AF and ChiOTEAF are two independent contemporary registries, carried out in Europe and China, respectively. ... remove battery virus now
Effects of the Atrial Fibrillation Better Care Pathway on Outcomes ...
WebPatients with Atrial Fibrillation (ChiOTEAF) registry provides contemporary manage-ment strategies among the elderly Chinese patients in the new era of non-vitamin K antagonists. Objective: To present the 1-year follow-up data from the ChiOTEAF registry, focus - ing on the use of antithrombotic therapy, rate vs. rhythm control strategies, and de- Web2 days ago · 製藥商莫德納(Moderna Inc)表示,預計2027年其呼吸道疫苗的銷售額將在80億至150億元之間。該公司在年度疫苗會議之前表示,預計將在未來幾年推出6種主要疫苗。莫德納正在測試針對呼吸道合胞病毒(RSV)、流感疫苗和處於後期研究階段的下一代新冠病毒疫 … WebIn the ongoing ChiOTEAF Registry study, the aims are to explore contemporary antithrombotic strategies amongst the Chinese elderly population in the new era of non-vitamin K antagonist oral anticoagulants (NOACs), and secondly, to compare the clinical characteristics and outcomes between the Chinese and European AF populations. remove battle net phone number